Extensive Study Questions Previous Study’s Analytic Methods Regarding Cardiovascular Safety Concerns Over Smoking-Cessation Drug
A popular smoking cessation medication has been under a cloud of suspicion ever since the Canadian Medical Association Journal (CMAJ) published a study in July 2011 reporting “risk of serious adverse cardiovascular events associated with varenicline.” …
